Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Life Sci ; 64(26): PL297-303, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10403513

RESUMO

Phosphorylation and dephosphorylation of neuronal proteins have been implicated in regulation of synaptic transmission. Studies were performed to determine if synaptophysin was phosphorylated or dephosphorylated during exposure of synaptosomes to botulinum toxin A (BoTX/A). Cholinergic-enriched synaptosomes were preincubated in the presence of 3H-choline to label newly synthesized acetylcholine (3H-ACh). This was followed by incubation with low or high potassium to stimulate release of newly synthesized 3H-ACh. BoTX/A inhibited total Ach release by 15-19% and inhibited release of newly synthesized 3H-ACh by 35%. A 165% increase in synaptophysin phosphorylation occurred in a dose-dependent manner over a range of doses (0.2 nM, 2 nM, 20 nM, 100 nM) of BoTX/A. When 4-Aminopyridine was added to synaptosomes that were BoTX/A treated, synaptophysin was dephosphorylated to control levels. Synaptosomes incubated with BoTX/A exhibited an inhibition of potassium stimulated ACh release and an increase in synaptophysin phosphorylation. Synaptophysin phosphorylation may be involved in inhibition of acetylcholine release.


Assuntos
Toxinas Botulínicas Tipo A/farmacologia , Córtex Cerebral/ultraestrutura , Sinaptofisina/metabolismo , Sinaptossomos/metabolismo , 4-Aminopiridina/farmacologia , Acetilcolina/biossíntese , Acetilcolina/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Toxinas Botulínicas Tipo A/antagonistas & inibidores , Relação Dose-Resposta a Droga , Exocitose/efeitos dos fármacos , Masculino , Fosfatos/metabolismo , Fosforilação/efeitos dos fármacos , Potássio/antagonistas & inibidores , Potássio/farmacologia , Bloqueadores dos Canais de Potássio , Ratos , Ratos Sprague-Dawley , Sinaptossomos/efeitos dos fármacos , Fatores de Tempo
2.
J Chromatogr B Biomed Sci Appl ; 695(1): 67-75, 1997 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-9271130

RESUMO

Capillary zone electrophoresis (CZE) was utilized to identify a synaptobrevin-thioredoxin fusion protein (TSB-51). TSB-51 is a substrate for cleavage by botulinum toxin B at the Q(76)-F(77) site. TSB-51 was derivatized with a fluorophore, CBQCA [3-(4-carboxy-benzoyl)-2-quinoline-carboxaldehyde], for 4 h at room temperature. Optimal conditions for CZE separation of the TSB-51-CBQCA complex were determined: buffer (sodium borate), pH (9.0), applied voltage (25 kV), temperature (25 degrees C) and forward polarity. SDS-PAGE showed that TSB-51 had a molecular mass of approximately 19 kDa. The protein was transferred to PVDF membrane and sequenced by the Edman degradation method verifying the first twelve amino acids as SDKIIHLTDDSF. TSB-51 was also collected during CZE separation and subsequently sequenced yielding the first three amino acids as SDK. This CZE-LIF method coupled with the CBQCA derivatization, fraction collection and Edman sequencing allowed for identification of the recombinant protein, a fast separation run time and utilization of small volumes of peptide (1.5 ng protein/23.6 nl injection). This method will be used for monitoring the endopeptidase activity of botulinum toxin B on TSB-51.


Assuntos
Proteínas de Membrana/análise , Proteínas Recombinantes de Fusão/análise , Tiorredoxinas/análise , Sequência de Aminoácidos , Benzoatos , Eletroforese Capilar , Eletroforese em Gel de Poliacrilamida , Corantes Fluorescentes , Concentração de Íons de Hidrogênio , Lasers , Dados de Sequência Molecular , Quinolinas , Proteínas R-SNARE , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Espectrometria de Fluorescência , Temperatura
3.
Life Sci ; 59(25-26): 2113-28, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8950315

RESUMO

Vesamicol (AH5183) is an inhibitor (IC50, 50 nM) of acetylcholine (ACh) vesicle packaging. Vesamicol increases the phosphorylation pattern of synaptophysin (p38), identified as a vesicle-specific phosphoprotein involved in vesicle-mediated neurotransmitter release. Percoll fractionation of the rat cortex yielded a cholinergic-enriched synaptosomal Fraction 4. Fraction 4 contained the highest enrichment of cholineacetyl-transferase activity (86 +/- 4.6 mumole AcCh/g protein/hr.) in the Percoll gradient. Fraction 4 demonstrated oxygen consumption (108 +/- 23.4 nmole/mg protein), levels of adenosine triphosphate, ATP, (10.29 +/- 0.45 nmole/mg protein) and adenosine diphosphate, ADP, (10.54 +/- 2.72 nmole/mg protein), energy potential (ATP/[ADP] [Pi], (0.49) phosphate uptake (65-80 nmoles phosphate/mg tissue), 32Pi labelling (130 +/- 12 x 10(5) DPM/mg tissue; 74 +/- 9.8 x 10(2) nmoles phosphate/mg tissue). Synaptophysin was identified by Western blotting and confirmed by qualitative immunoprecipitation. Synaptophysin phosphorylation was confirmed by autoradiograph. Synaptophysin phosphorylation increased (225%) in the presence of vesamicol (ED50, 1 nM) in Fraction 4. Vesamicol (50 nM) and vanadate (54 microM) were compared for their effects on synaptophysin. This study suggests that during the inhibition of acetylcholine packaging by vesamicol that synaptophysin is phosphorylated. Therefore, the phosphorylation and dephosphorylation of synaptophysin may be involved in the transport of acetylcholine in or out of the synaptic vesicle.


Assuntos
Acetilcolina/antagonistas & inibidores , Córtex Cerebral/efeitos dos fármacos , Fármacos Neuromusculares Despolarizantes/farmacologia , Piperidinas/farmacologia , Sinaptofisina/metabolismo , Sinaptossomos/efeitos dos fármacos , Acetilcolina/metabolismo , Animais , Córtex Cerebral/citologia , Córtex Cerebral/metabolismo , Ácido Dicloroacético/farmacologia , Metabolismo Energético , Masculino , Oxigênio/metabolismo , Fosfatos/metabolismo , Fosforilação , Ratos , Ratos Sprague-Dawley , Sinaptossomos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...